Loss of balance between protective and pro-inflammatory synovial tissue T-cell polyfunctionality predates clinical onset of rheumatoid arthritis.


Journal

Annals of the rheumatic diseases
ISSN: 1468-2060
Titre abrégé: Ann Rheum Dis
Pays: England
ID NLM: 0372355

Informations de publication

Date de publication:
02 2022
Historique:
received: 31 03 2021
accepted: 10 09 2021
pubmed: 3 10 2021
medline: 11 2 2022
entrez: 2 10 2021
Statut: ppublish

Résumé

This study investigates pathogenic and protective polyfunctional T-cell responses in patient with rheumatoid arthritis (RA), individuals at risk (IAR) and healthy control (HC) synovial-tissue biopsies and identifies the presence of a novel population of pathogenic polyfunctional T-cells that are enriched in the RA joint prior to the development of clinical inflammation. Pathway enrichment analysis of previously obtained RNAseq data of synovial biopsies from RA (n=118), IAR (n=20) and HC (n=44) was performed. Single-cell synovial tissue suspensions from RA (n=10), IAR (n=7) and HC (n=7) and paired peripheral blood mononuclear cells (PBMC) were stimulated in vitro and polyfunctional synovial T-cell subsets examined by flow cytometric analysis, simplified presentation of incredibly complex evaluations (SPICE) and FlowSom clustering. Flow-imaging was utilised to confirm specific T-cell cluster identification. Fluorescent lifetime imaging microscopy (FLIM) was used to visualise metabolic status of sorted T-cell populations. Increased plasticity of Tfh cells and CD4 T-cell polyfunctionality with enriched memory Treg cell responses was demonstrated in RA patient synovial tissue. Synovial-tissue RNAseq analysis reveals that enrichment in T-cell activation and differentiation pathways pre-dates the onset of RA. Switch from potentially protective IL-4 and granulocyte macrophage colony stimulating factor (GMCSF) dominated polyfunctional CD4 T-cell responses towards pathogenic polyfunctionality is evident in patient with IAR and RA synovial tissue. Cluster analysis reveals the accumulation of highly polyfunctional CD4 Switch from potentially protective to pathogenic T-cell polyfunctionality pre-dates the onset of clinical inflammation and constitutes an opportunity for therapeutic intervention in RA.

Identifiants

pubmed: 34598926
pii: annrheumdis-2021-220458
doi: 10.1136/annrheumdis-2021-220458
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

193-205

Commentaires et corrections

Type : ErratumIn

Informations de copyright

© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Achilleas Floudas (A)

Department of Molecular Rheumatology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland.

Nuno Neto (N)

Department of Mechanical and Manufacturing Engineering, Trinity College Dublin, Dublin, Ireland.
Department of Mechanical and Manufacturing Engineering, Trinity College Dublin, Dublin, Ireland.

Carl Orr (C)

Department of Rheumatology, EULAR Centre of excellence, Centre for Arthritis and Rheumatic Diseases, St Vincent's University Hospital, UCD, Dublin, Ireland.

Mary Canavan (M)

Department of Molecular Rheumatology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland.

Phil Gallagher (P)

Department of Orthopaedics, St Vincent's University Hospital, Dublin, Ireland.

Conor Hurson (C)

Department of Orthopaedics, St Vincent's University Hospital, Dublin, Ireland.

Michael G Monaghan (MG)

Department of Mechanical and Manufacturing Engineering, Trinity College Dublin, Dublin, Ireland.

Sunil Nagpar (S)

Department of Immunology, Janssen Research & Development, Immunology, Philadelphia, Pennsylvania, USA.

Ronan H Mullan (RH)

Department of Rheumatology, Tallaght University Hospital, Dublin, Dublin, Ireland.

Douglas J Veale (DJ)

Department of Rheumatology, EULAR Centre of excellence, Centre for Arthritis and Rheumatic Diseases, St Vincent's University Hospital, UCD, Dublin, Ireland.

Ursula Fearon (U)

Department of Molecular Rheumatology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland Fearonu@tcd.ie.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH